ASTHENEIA BIO

At Astheneia Bio, our mission is to develop first in class and first line therapies using different platforms. Astheneia Bio's dual-immunotherapy platform will revolutionize the access, speed, efficiency, and cost by which cancer patients are treated for their disease... Astheneia Bio's neutrophil technology is different than other cell therapies. Astheneia's technology produces genetically modified neutrophils to target and destroy solid tumors. CAR-neutrophils can carry and deliver nanodrugs to the local tumor site.